BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ulthera Announces Issuance of Patent for New Medical Field of Use


10/12/2012 9:27:32 AM

MESA, AZ--(Marketwire - October 12, 2012) -

Ulthera, Inc. -- a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology -- announces the issuance of U.S. Patent No. 8,282,554 this week from the U.S. Patent and Trademark Office (USPTO). The patent, titled "Methods for Treatment of Sweat Glands" relates to the therapeutic use of energy for the treatment of conditions resulting from sweat gland disorders, such as hyperhidrosis.

"This new patent adds a significant asset to the patent portfolio for Ulthera, which has rights to over 100 U.S. and international patents that are issued, published or pending," said Matthew Likens, Ulthera's president and CEO. "The groundbreaking advances underlying this patent are a result of many years of collaboration between Ulthera and Guided Therapy Systems, LLC, a global innovator of ultrasound-based technology."

"It coincides nicely with our recent IDE approval to initiate a pivotal clinical study on axillary (underarm) hyperhidrosis," Likens continued. "With three percent of the general population profoundly affected by the medical condition and many more who consider themselves 'sweat-bothered,' excessive sweating is an area of keen interest to us, and to our core customer base. The potential to treat a medical condition and positively impact a patient's quality of life is a logical progression for our platform technology."

About Ulthera
Ulthera, Inc. is a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Arizona, Ulthera is a privately held company backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ultherapy.com.


Media Contact:
Susan Sorensen
Janice Lipsky
Email Contact
480.619.4069

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

Ulthera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->